Mid-regional proadrenomedullin is a good prognostic marker for patients in the Intensive Care Unit with sepsis.

MLA

Fahmy, Alaa A., et al. “Mid-Regional Proadrenomedullin Is a Good Prognostic Marker for Patients in the Intensive Care Unit with Sepsis.” Critical Care & Shock, vol. 25, no. 6, Nov. 2022, pp. 309–16. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=160445230&authtype=sso&custid=ns315887.

APA

Fahmy, A. A., Azab, M. M., Amr, G. E., Matar, H. M., & Sediq, A. M. (2022). Mid-regional proadrenomedullin is a good prognostic marker for patients in the Intensive Care Unit with sepsis. Critical Care & Shock, 25(6), 309–316.

Chicago

Fahmy, Alaa A., Mervat Mostafa Azab, Ghada Elsayed Amr, Heba M. Matar, and Amany Mohyeldin Sediq. 2022. “Mid-Regional Proadrenomedullin Is a Good Prognostic Marker for Patients in the Intensive Care Unit with Sepsis.” Critical Care & Shock 25 (6): 309–16. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=160445230&authtype=sso&custid=ns315887.